U.S. Markets open in 3 hrs 30 mins

Elbit Imaging Ltd. (EMITF)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.22-0.02 (-0.62%)
At close: 4:00PM EDT
People also watch
  • Found a great no fee daytrading newsletter, vist T0pMarketGaIners.c0m and sign up...so glad I did
  • Crush the NASDAQ & NYSE with the Biggest Winners from T0pMarketGainers.c0m
  • Found a great no fee daytrading newsletter, vist T0pMarketGaIners.c0m and sign up...so glad I did
  • These guys are churning out winners like sea turtle eggs I swear. Google UltimeteStockAlertsQ and you’ll see!
  • Elbit Imaging Ltd. Announces That INSIGHTEC's Exablate Neuro System Has Been Approved by CMS for U.S. Coverage for the Treatment of Essential Tremor

    GlobeNewswire•November 16, 2016
    TEL AVIV, Israel, Nov. 16, 2016 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (EMITF) (EMITF) ("Elbit" or the "Company") announced today that it was informed by INSIGHTEC Ltd. ("INSIGHTEC"), that the Centers for Medicare and Medicaid Services (the "CMS") assigned a status to the Exablate Neuro treatment for Essential Tremor, moving it from a non-payable status indicator to one that allows reimbursement.

    The CMS decision is one of several steps toward gaining appropriate reimbursement for MRgFUS for essential tremor. This needs to be followed by CMS regional offices approval to the reimbursement for the Exablate Neuro treatment, for their patients.

    According to the CMS's recommendation, the Exablate Neuro was assigned a reimbursement code with a payment level of $9751.

    The CMS is part of the U.S. Department of Health and Human Services, and it oversees, among its other functions, Medicare (the federal health insurance program for the elderly, [which are the main group of potential patients for the Exablate Neuro treatment]), and Medicare reimbursement rates for healthcare providers that use federally certified health IT systems.

    At this stage, INSIGHTEC is unable to estimate the implications of the CMS's recommendation on INSIGHTEC.

    INSIGHTEC’s Exablate Neuro platform is transforming medicine by presenting a non-invasive treatment alternative that combines two technologies: Focused Ultrasound, which is used to lesion the targeted tissue deep in the brain, and Magnetic Resonance Imaging (MRI), which is used to guide the ultrasound waves to the specific target tissue and provide real-time feedback on treatment progress and outcomes.

    Essential tremor is the most common movement disorder, affecting millions people worldwide. It is a progressive and debilitating neurological condition that causes a rhythmic trembling of the hands, head, voice, legs or trunk.

    The Company holds approximately 89.9% of the share capital of Elbit Medical Technologies Ltd. (TASE:EMTC-M) (85.6% on a fully diluted basis) which, in turn, holds approximately 31.3% of the share capital in INSIGHTEC (26.6% on a fully diluted basis).
  • www.PennyStock101.org is one of the best “alerts” services I have found. Just sign up and watch from the sidelines, you will see!

    PennyStock101 - Lesson #1
  • Alert about $EMITF on http://otc.ninja/?s=EMITF

  • EMITF about to double ? video at STOCKTRADEVIDEO (Google them)
  • Sale of the Plaza Property is proceeding and expected to close before the end of the year. Potential asset value 13-39 dollars a share.
  • Insightetc is with a 250 million valuation its valuation on last money raise is the equivalent of 7.5 dollars per share of Emitf. Insightec is going IPO first Q of 2018. What with EMITF be trading for? If Isightec realizes a 500 million valuation on the IPO EMITF has the equivalent of 15dollars per share of Insightec.
  • I found $EMITF on http://otc.report/?s=EMITF

  • 10/19/16 -- The InSightec (owned by EMITF) neuro procedure was featured on Charlie Rose (PBS). This will largely replace Deep Brain Stimulation as remedy for Essential Tremor. Worth billions.
  • Doctor Elias and Dr Kassell at Infocus are doing Amazing Work with the Laser Technology. If this is part of their work this Technology will become the Standard.
  • Potential Swing Failure - Video at HOTSTOCKTRADE (Google them) - EMITF
  • Elbit Imaging Announces Closing of Debt Repayment Agreement With Financing Bank and Sale of Zgorzelec Plaza Shopping Center in Poland by Its Subsidiary, Plaza Centers
  • You can't build a reputation on what you are going to do. http://dataunion.tistory.com/1814

    [2016-MAY] Elbit Imaging Ltd NASDAQ : EMITF Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.8 In other words, the correlation coefficient of the other stoc
  • Pivotal Study Results Published in New England Journal of Medicine (NEJM) Confirm Safety and Efficacy of INSIGHTEC's Exablate Neuro System for the Treatment of Essential Tremor

    The study met its primary endpoint with patients treated with Exablate Neuro demonstrating a clinically significant 47% improvement in a composite tremor score at three months as compared to no change in the sham cohort.
  • Good mornings fellow investors.. Remember me? Still hanging around with my 6667 shares after R/S..still hopeful..looks like the company is making a comeback..holding long term..we shall see where this company take us in term of share price..anyone wanna take a guess?
  • Elbit Imaging announces availability of investor
    relations presentation on its website.
    Structure of the Company’s holdings
    • The Company has two main shareholders: York Capital and its affiliates (“York”) hold approximately 19.7% of the
    Company’s share capital and Davidson-Kampner and its affiliates (“DK”) hold approximately 14.3% of the
    Company’s share capital.
    • Rest of the shares are held by the public.

    The Company’s Business segments are:
    • Operation and management of Radisson hotel Complex in Bucharest, Romania.
    • Through our subsidiary, Elbit Medical technologies Ltd (“Elbit Medical”) (90% and 86% fully diluted), we hold two
    companies: InSightec (~26% fully diluted) and Gamida Cell (~23% fully diluted).
    • Through our subsidiary ,Plaza Centers (~45%), – initiation, construction, operation, management and sale of real
    estate projects mainly commercial centers in Europe.
    • Land Plots in India (in partnership with Plaza Centers).

    A very comprehensive presentation indeed!